SEC Form 4 · accession 0001144204-19-005339
AVENUE THERAPEUTICS, INC. · ATXI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Neil Herskowitz
Director
Period of report
Feb 4, 2019
Accepted (ET)
Feb 6, 2019 · 4:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001644963
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 4, 2019 | P | 7,000 | $5.91 | A | 84,813 | D | |
| Common StockF2 | Feb 5, 2019 | P | 1,850 | $5.77 | A | 86,663 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects the weighted average purchase price of multiple same-day open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the purchase transactions on February 4, 2019 was $5.90 to $5.97. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
- F2Includes 64,663 shares of restricted stock.